Fortunato Ciardiello

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Circulating Tumor

Radical Prostatectomy

Decision Making

Top Venues

Exploration of targeted anti-tumor therapy

Future oncology (London, England)

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Nicola Normanno, Vincenza Caridi, Angelo Paolo Dei Tos, Antonio Avallone, Fortunato Ciardiello, Carmine Pinto
Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity? Exploration of targeted anti-tumor therapy 5 (3) (2024)
Nicola Normanno, Vincenza Caridi, Angelo Paolo Dei Tos, Antonio Avallone, Fortunato Ciardiello, Carmine Pinto
Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity? Exploration of targeted anti-tumor therapy 5 (3) (2024)
Carsten Bokemeyer, Fortunato Ciardiello, Olivier Dubreuil, Joel Guigay, Stefan Kasper, Per Pfeiffer, Carmine Pinto, Kensei Yamaguchi, Takayuki Yoshino, Christoph C Zielinski, Regina Esser, Josep Tabernero
Cetuximab every 2 weeks versus standard weekly dosing administration schedule. Future oncology (London, England) (2023)
Vincenza Caputo, Fortunato Ciardiello, Carminia Maria Della Corte, Giulia Martini, Teresa Troiani, Stefania Napolitano
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer. Exploration of targeted anti-tumor therapy 4 (1) (2023)
Vincenza Caputo, Fortunato Ciardiello, Carminia Maria Della Corte, Giulia Martini, Teresa Troiani, Stefania Napolitano
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer. Exploration of targeted anti-tumor therapy 4 (1) (2023)
Giulia Martini, Davide Ciardiello, Marcello Dallio, Vincenzo Famiglietti, Lucia Esposito, Carminia Maria Della Corte, Stefania Napolitano, Morena Fasano, Antonietta Gerarda Gravina, Marco Romano, Carmelina Loguercio, Alessandro Federico, Evaristo Maiello, Concetta Tuccillo, Floriana Morgillo, Teresa Troiani, Massimo Di Maio, Erika Martinelli, Fortunato Ciardiello
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab. International journal of cancer 151 (3) (2022)